• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异丙肾上腺素和氨茶碱对支气管哮喘患者的支气管扩张作用定位:一项使用选择性肺泡支气管造影术的研究

Localization of the bronchodilatory effects of isoproterenol and aminophylline in patients with bronchial asthma: an investigation using selective alveolobronchography.

作者信息

Murata T, Imamura M, Taniguchi M, Tanaka Y

机构信息

Department of Radiology, Kansai Medical University, Osaka, Japan.

出版信息

J Int Med Res. 1997 Nov-Dec;25(6):325-39. doi: 10.1177/030006059702500603.

DOI:10.1177/030006059702500603
PMID:9427166
Abstract

The effect of isoproterenol (isoprenaline) and aminophylline on airway calibre in 18 adult patients with bronchial asthma was measured directly using selective alveolobronchography. Isoproterenol caused a significant dilation in the maximal calibre of the central airway from bifurcation numbers 1-5 (P < 0.05) and number 6 (P < 0.01). There was no change in bifurcation number 0 (trachea). Aminophylline caused a significant dilatation in bifurcation numbers 3 and 4 (P < 0.01), with no change in bifurcation numbers 0-2 and 5-6. In the minimal calibre of the central airway, both drugs displayed a significant dilatory effect only at bifurcation number 3 (P < 0.05). These results indicate that the central airway is the main site of the dilatory effects of these drugs. Although their precise mechanisms of action are not known, these results suggest that mechanisms of action of the two drugs are different. Isoproterenol acts on the whole region of the central airway, while the action of aminophylline tends to be limited to bifurcation numbers 3 and 4.

摘要

采用选择性肺泡支气管造影术直接测量了18例成年支气管哮喘患者异丙肾上腺素(喘息定)和氨茶碱对气道管径的影响。异丙肾上腺素使第1 - 5级和第6级中央气道的最大管径显著扩张(第1 - 5级,P < 0.05;第6级,P < 0.01)。第0级(气管)无变化。氨茶碱使第3级和第4级气道显著扩张(P < 0.01),第0 - 2级和第5 - 6级无变化。在中央气道的最小管径处,两种药物仅在第3级显示出显著的扩张作用(P < 0.05)。这些结果表明中央气道是这些药物扩张作用的主要部位。尽管它们的确切作用机制尚不清楚,但这些结果提示两种药物的作用机制不同。异丙肾上腺素作用于中央气道的整个区域,而氨茶碱的作用倾向于局限于第3级和第4级。

相似文献

1
Localization of the bronchodilatory effects of isoproterenol and aminophylline in patients with bronchial asthma: an investigation using selective alveolobronchography.异丙肾上腺素和氨茶碱对支气管哮喘患者的支气管扩张作用定位:一项使用选择性肺泡支气管造影术的研究
J Int Med Res. 1997 Nov-Dec;25(6):325-39. doi: 10.1177/030006059702500603.
2
Isoprenaline and aminophylline relax bronchial smooth muscle by cAMP-induced stimulation of large-conductance Ca2+-activated K+ channels.异丙肾上腺素和氨茶碱通过环磷酸腺苷(cAMP)诱导的大电导钙激活钾通道刺激来舒张支气管平滑肌。
Acta Pharmacol Sin. 2003 May;24(5):408-14.
3
Synthesis and bronchodilatory activity of four new derivatives of deoxyvasicine.
Drug Des Discov. 1996 Mar;14(1):1-14.
4
Comparative effect of amrinone, aminophylline and diltiazem on rat airway smooth muscle.
Acta Anaesthesiol Scand. 2000 Jul;44(6):763-6. doi: 10.1034/j.1399-6576.2000.440617.x.
5
Effective site of bronchodilation by antiasthma drugs in subjects with asthma.
J Allergy Clin Immunol. 1991 Jun;87(6):1080-7. doi: 10.1016/0091-6749(91)92153-r.
6
Response of blood gas tensions to aminophylline and isoprenaline in patients with asthma.哮喘患者血气张力对氨茶碱和异丙肾上腺素的反应。
Thorax. 1967 Nov;22(6):543-9. doi: 10.1136/thx.22.6.543.
7
Synergistic effects of ularitide acetate with classical bronchorelaxants on guinea-pig tracheal smooth muscle.
Arzneimittelforschung. 1998 May;48(5):475-81.
8
[The effect of bronchodilator on ventilatory response during CO2 rebreathing in patients with asthma].[支气管扩张剂对哮喘患者二氧化碳重复呼吸期间通气反应的影响]
Kokyu To Junkan. 1987 Apr;35(4):423-30.
9
[Lung elasticity in bronchial asthma (author's transl)].[支气管哮喘中的肺弹性(作者译)]
Rev Med Chil. 1977 May;105(5):293-6.
10
[Broncho-active substances. Aspects of their physiology and their diagnostic and clinical applications].[支气管活性物质。其生理学、诊断及临床应用方面]
Allergol Immunopathol (Madr). 1974 Sep-Oct;2(5):343-62.